These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2527790)

  • 21. Central nitric oxide blocks vasopressin, oxytocin and atrial natriuretic peptide release and antidiuretic and natriuretic responses induced by central angiotensin II in conscious rats.
    Reis WL; Giusti-Paiva A; Ventura RR; Margatho LO; Gomes DA; Elias LL; Antunes-Rodrigues J
    Exp Physiol; 2007 Sep; 92(5):903-11. PubMed ID: 17513344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Atrial natriuretic peptide: clinical perspectives].
    Fernández-Cruz A
    Rev Clin Esp; 1987 Jun; 181(1):49-51. PubMed ID: 2957756
    [No Abstract]   [Full Text] [Related]  

  • 23. [Sodium and water imbalance in liver cirrhosis. Clinical aspects, pathogenesis and therapeutic consequences].
    Brunkhorst R
    Fortschr Med; 1993 Apr; 111(11):186-7. PubMed ID: 8508995
    [No Abstract]   [Full Text] [Related]  

  • 24. Natriuresis of volume expansion and atrial factors: contrasts and comparisons.
    Gyory AZ; Reddy S; Kelly D; Cochineas C
    Prog Biochem Pharmacol; 1988; 23():61-70. PubMed ID: 2973068
    [No Abstract]   [Full Text] [Related]  

  • 25. [Atrial receptors, atrial natriuretic peptides and renal natriuretic responses].
    Zhu JL
    Sheng Li Ke Xue Jin Zhan; 1989 Jul; 20(3):258-60. PubMed ID: 2532786
    [No Abstract]   [Full Text] [Related]  

  • 26. Mechanisms of release and renal tubular action of atrial natriuretic factor.
    Sonnenberg H
    Fed Proc; 1986 Jun; 45(7):2106-10. PubMed ID: 3011520
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemodynamic and renal effects of atrial natriuretic factor in portal hypertensive rats. Potentiation by Phe-Ile-Orn-vasopressin.
    Ganger DR; Gottstein J; Blei AT
    J Pharmacol Exp Ther; 1988 Sep; 246(3):941-5. PubMed ID: 2971104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pathophysiologic and clinical relevance of atrial natriuretic factor in patients with cirrhosis of the liver].
    Gerbes AL; Arendt R; Xie Y; Knorr HJ; Riedel A; Paumgartner G
    Z Kardiol; 1988; 77 Suppl 2():99-103. PubMed ID: 2970181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paradoxical relationship between atriopeptin plasma levels and diuresis-natriuresis induced by acute volume expansion.
    Sakata M; Greenwald JE; Needleman P
    Proc Natl Acad Sci U S A; 1988 May; 85(9):3155-9. PubMed ID: 2966400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Studies on the role of heart innervation and other non-osmotic factors in regulating water and sodium metabolism].
    Pruszczyński W
    Pol Tyg Lek; 1988 Sep; 43(36):1169-72. PubMed ID: 2977990
    [No Abstract]   [Full Text] [Related]  

  • 31. Atrial natriuretic factor. A newly discovered hormone with significant clinical implications.
    Thibault G; Garcia R; Gutkowska J; Genest J; Cantin M
    Drugs; 1986 May; 31(5):369-75. PubMed ID: 2872046
    [No Abstract]   [Full Text] [Related]  

  • 32. [Atrial natriuretic peptides].
    Moeller H
    Dtsch Med Wochenschr; 1986 Feb; 111(6):226-8. PubMed ID: 2935384
    [No Abstract]   [Full Text] [Related]  

  • 33. [Natriuretic atrial peptide--what is the mechanism of natriuresis?].
    Sadowski J; Badzyńska B
    Pol Tyg Lek; 1991 Jan 21-28; 46(4-5):63-6. PubMed ID: 1845695
    [No Abstract]   [Full Text] [Related]  

  • 34. Thiorphan-induced natriuresis in volume-expanded rats: roles of endogenous atrial natriuretic factor and kinins.
    Bralet J; Mossiat C; Gros C; Schwartz JC
    J Pharmacol Exp Ther; 1991 Sep; 258(3):807-11. PubMed ID: 1653839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atrial natriuretic peptide: renal effects in cirrhosis of the liver.
    Levy M
    Semin Nephrol; 1997 Nov; 17(6):520-9. PubMed ID: 9353863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac natriuretic peptides in heart failure.
    Nicholls MG; Richards AM; Crozier IG; Espiner EA; Ikram H
    Ann Med; 1993 Dec; 25(6):503-5. PubMed ID: 8292296
    [No Abstract]   [Full Text] [Related]  

  • 37. [Renal resistance to atrial natriuretic factor as a cause of the escape failure phenomenon in patients with non-ascitic liver cirrhosis].
    Tesar V; Spicák J; Horký K; Zabka J; Widimský J; Jedlicka J; Marecek Z
    Cas Lek Cesk; 1994 Feb; 133(4):111-5. PubMed ID: 8137382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natriuretic response to atrial natriuretic factor enhanced by angiotensin II and vasopressin.
    Trippodo NC; MacPhee AA; Cole FE
    J Hypertens Suppl; 1984 Dec; 2(3):S289-91. PubMed ID: 6242556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal prostaglandins and natriuretic action of oxytocin and vasopressin in rats.
    Chan WY
    J Pharmacol Exp Ther; 1988 Aug; 246(2):603-9. PubMed ID: 3165443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Renal mechanisms responsible for natriuresis caused by atrial natriuretic factor].
    Juvin P; Bichara M
    Ann Fr Anesth Reanim; 1991; 10(6):601. PubMed ID: 1838465
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.